Analyses of risk factors for polycystic ovary syndrome complicated with non-alcoholic fatty liver disease

Zhang,Jianhai; Hu,Jian; Zhang,Chunxia; Jiao,Yanni; Kong,Xiang; Wang,Wei

doi:10.3892/etm.2018.5932

Analyses of risk factors for polycystic ovary syndrome complicated with non-alcoholic fatty liver disease

Authors:
- Jianhai Zhang
- Jian Hu
- Chunxia Zhang
- Yanni Jiao
- Xiang Kong
- Wei Wang
View Affiliations

Affiliations: Department of Obstetrics and Gynecology, Shengli Oilfield Central Hospital, Dongying, Shandong 257034, P.R. China
Published online on: March 6, 2018 https://doi.org/10.3892/etm.2018.5932
Pages: 4259-4264
Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The risk factors related to polycystic ovary syndrome (PCOS) patients complicated with non-alcoholic fatty liver disease (NAFLD) were investigated. A total of 188 PCOS patients treated in Shengli Oilfield Central Hospital (Dongying, China) from February 2014 to February 2015 were retrospectively analyzed as PCOS group, and PCOS group was further divided into NAFLD group and non-NAFLD (N-NAFLD) group according to the liver B ultrasound. In the same time-period, 65 healthy people were selected as normal control group. The differences of clinical, biochemical and metabolic indexes were compared. The levels of luteinizing hormone (LH), LH/follicle stimulating hormone (FSH), testosterone (T), free androgen index (FAI), fasting insulin (FINS) and homeostasis model assessment of insulin resistance (HOMA‑IR) index in PCOS group were higher than those in normal control group, but the sex hormone binding globulin (SHBG) level was lower than that in normal control group (p<0.05); there were no statistically significant differences in comparisons of age, body mass index (BMI), waist-hip ratio (WHR), FSH, dehydroepiandrosterone sulfate (DHEAs) and fasting blood glucose (FBG) between the two groups (p>0.05).The prevalence rate of NAFLD in PCOS group (44.68%) was significantly higher than that in control group (24.62%) (p<0.05). The proportion of NAFLD in PCOS patients in obesity group (63.51%) was significantly higher than that in non-obesity group (15.79%) (p<0.05). In PCOS group, NAFLD patients had more obvious metabolic abnormalities [high BMI, WHR, FBG, FINS, HOMA-IR index, total cholesterol (TC) and triglyceride (TG), and low high-density lipoprotein HDL and SHBG] and androgen excess compared with those in N-NAFLD patients (p<0.05). The levels of LH, LH/FSH, FINS and HOMA-IR index in PCOS group complicated with NAFLD were higher than those in control group complicated with NAFLD (p<0.05), but the differences in age, BMI, WHR, FSH and FBG levels were not statistically significant between the two groups (p>0.05). HOMA-IR index, BMI, WHR and TG were independent risk factors for PCOS complicated with NAFLD (p<0.05).

View Figures

View References

1	Joham AE, Teede HJ, Ranasinha S, Zoungas S and Boyle J: Prevalence of infertility and use of fertility treatment in women with polycystic ovary syndrome: Data from a large community-based cohort study. J Womens Health (Larchmt). 24:299–307. 2015. View Article : Google Scholar : PubMed/NCBI
2	Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group: Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 19:41–47. 2004. View Article : Google Scholar : PubMed/NCBI
3	Brunt EM: Nonalcoholic steatohepatitis: Definition and pathology. Semin Liver Dis. 21:3–16. 2001. View Article : Google Scholar : PubMed/NCBI
4	Kelley CE, Brown AJ, Diehl AM and Setji TL: Review of nonalcoholic fatty liver disease in women with polycystic ovary syndrome. World J Gastroenterol. 20:14172–14184. 2014. View Article : Google Scholar : PubMed/NCBI
5	Gambarin-Gelwan M, Kinkhabwala SV, Schiano TD, Bodian C, Yeh HC and Futterweit W: Prevalence of nonalcoholic fatty liver disease in women with polycystic ovary syndrome. Clin Gastroenterol Hepatol. 5:496–501. 2007. View Article : Google Scholar : PubMed/NCBI
6	Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF and Turner RC: Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 28:412–419. 1985. View Article : Google Scholar : PubMed/NCBI
7	Brzozowska MM, Ostapowicz G and Weltman MD: An association between non-alcoholic fatty liver disease and polycystic ovarian syndrome. J Gastroenterol Hepatol. 24:243–247. 2009. View Article : Google Scholar : PubMed/NCBI
8	Ortiz-Lopez C, Lomonaco R, Orsak B, Finch J, Chang Z, Kochunov VG, Hardies J and Cusi K: Prevalence of prediabetes and diabetes and metabolic profile of patients with nonalcoholic fatty liver disease (NAFLD). Diabetes Care. 35:873–878. 2012. View Article : Google Scholar : PubMed/NCBI
9	Teede HJ, Meyer C, Hutchison SK, Zoungas S, McGrath BP and Moran LJ: Endothelial function and insulin resistance in polycystic ovary syndrome: The effects of medical therapy. Fertil Steril. 93:184–191. 2010. View Article : Google Scholar : PubMed/NCBI
10	Kauffman RP, Baker TE, Baker V, Kauffman MM and Castracane VD: Endocrine factors associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome: Do androgens play a role? Gynecol Endocrinol. 26:39–46. 2010. View Article : Google Scholar : PubMed/NCBI
11	Setji TL, Holland ND, Sanders LL, Pereira KC, Diehl AM and Brown AJ: Nonalcoholic steatohepatitis and nonalcoholic Fatty liver disease in young women with polycystic ovary syndrome. J Clin Endocrinol Metab. 91:1741–1747. 2006. View Article : Google Scholar : PubMed/NCBI
12	Sorrentino P, Tarantino G, Conca P, Perrella A, Terracciano ML, Vecchione R, Gargiulo G, Gennarelli N and Lobello R: Silent non-alcoholic fatty liver disease-a clinical-histological study. J Hepatol. 41:751–757. 2004. View Article : Google Scholar : PubMed/NCBI
13	Omagari K, Kadokawa Y, Masuda J, Egawa I, Sawa T, Hazama H, Ohba K, Isomoto H, Mizuta Y, Hayashida K, et al: Fatty liver in non-alcoholic non-overweight Japanese adults: Incidence and clinical characteristics. J Gastroenterol Hepatol. 17:1098–1105. 2002. View Article : Google Scholar : PubMed/NCBI
14	Xia MF, Yan HM, He WY, Li XM, Li CL, Yao XZ, Li RK, Zeng MS and Gao X: Standardized ultrasound hepatic/renal ratio and hepatic attenuation rate to quantify liver fat content: An improvement method. Obesity (Silver Spring). 20:444–452. 2012. View Article : Google Scholar : PubMed/NCBI
15	Gramlich T, Kleiner DE, McCullough AJ, Matteoni CA, Boparai N and Younossi ZM: Pathologic features associated with fibrosis in nonalcoholic fatty liver disease. Hum Pathol. 35:196–199. 2004. View Article : Google Scholar : PubMed/NCBI
16	Menzaghi C, Trischitta V and Doria A: Genetic influences of adiponectin on insulin resistance, type 2 diabetes, and cardiovascular disease. Diabetes. 56:1198–1209. 2007. View Article : Google Scholar : PubMed/NCBI
17	Choi JH, Rhee EJ, Bae JC, Park SE, Park CY, Cho YK, Oh KW, Park SW and Lee WY: Increased risk of type 2 diabetes in subjects with both elevated liver enzymes and ultrasonographically diagnosed nonalcoholic fatty liver disease: A 4-year longitudinal study. Arch Med Res. 44:115–120. 2013. View Article : Google Scholar : PubMed/NCBI
18	Marchesini G, Avagnina S, Barantani EG, Ciccarone AM, Corica F, DallAglio E, Dalle Grave R, Morpurgo PS, Tomasi F and Vitacolonna E: Aminotransferase and gamma-glutamyltranspeptidase levels in obesity are associated with insulin resistance and the metabolic syndrome. J Endocrinol Invest. 28:333–339. 2005. View Article : Google Scholar : PubMed/NCBI
19	Brown AJ, Tendler DA, McMurray RG and Setji TL: Polycystic ovary syndrome and severe nonalcoholic steatohepatitis: Beneficial effect of modest weight loss and exercise on liver biopsy findings. Endocr Pract. 11:319–324. 2005. View Article : Google Scholar : PubMed/NCBI
20	Lee S, Jin Kim Y, Yong Jeon T, Hoi Kim H, Woo Oh S, Park Y and Soo Kim S: Obesity is the only independent factor associated with ultrasound-diagnosed non-alcoholic fatty liver disease: A cross-sectional case-control study. Scand J Gastroenterol. 41:566–572. 2006. View Article : Google Scholar : PubMed/NCBI
21	Ohashi K, Ouchi N, Kihara S, Funahashi T, Nakamura T, Sumitsuji S, Kawamoto T, Matsumoto S, Nagaretani H, Kumada M, et al: Adiponectin I164T mutation is associated with the metabolic syndrome and coronary artery disease. J Am Coll Cardiol. 43:1195–1200. 2004. View Article : Google Scholar : PubMed/NCBI
22	Vassilatou E, Lafoyianni S, Vryonidou A, Ioannidis D, Kosma L, Katsoulis K, Papavassiliou E and Tzavara I: Increased androgen bioavailability is associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome. Hum Reprod. 25:212–220. 2010. View Article : Google Scholar : PubMed/NCBI